Assessment of Plasma C-Reactive Protein as a Biomarker of Posttraumatic Stress Disorder RiskSatish A. Eraly, Dewleen G. Baker, Caroline M. Nievergelt et al.|JAMA Psychiatry|2014Cited by 391
Rituximab for High-Risk, Mature B-Cell Non-Hodgkin’s Lymphoma in ChildrenVéronique Minard‐Colin, Thomas G. Gross, Anne Aupérin et al.|New England Journal of Medicine|2020Cited by 308
Frequency of Pathogenic Germline Variants in Cancer-Susceptibility Genes in Patients With OsteosarcomaSharon A. Savage, Miriam Gutiérrez-Jimeno, Massimo Serra et al.|JAMA Oncology|2020Cited by 251
Genomic Classification and Clinical Outcome in Rhabdomyosarcoma: A Report From an International ConsortiumJack F. Shern, Javed Khan, Joanna Selfe et al.|Journal of Clinical Oncology|2021Cited by 221
<b>Germline Cancer Predisposition Variants in</b> <b>Pediatric Rhabdomyosarcoma: A Report From the Children’s Oncology Group</b>He Li, Philip J. Lupo, Saumya D. Sisoudiya et al.|JNCI Journal of the National Cancer Institute|2020Cited by 111